In healthcare and life sciences, core principles remain steadfast: scientific rigor, adherence to regulatory standards and an unwavering commitment to patient trust. Yet, with the emergence of agentic ...

Artificial intelligence has the potential to transform how life sciences companies engage with patients, physicians, and the broader healthcare ecosystem. But while the promise is real, so are the ...

Whether or not humans are ready, AI predictions are quietly set to become part of end-of-life medical decisions. Could an artificial intelligence algorithm used for end-of-life care decisions predict ...

LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 30, 2025 / Today, eXoZymes Inc. (EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into ...

Life sciences leaders say AI agents will be "essential" within two years. 97% say trusted data is essential for effective use of AI agents. 81% of R&D leaders surveyed are "very excited" about using ...

SAN FRANCISCO—Hippocratic AI is building out its life sciences division to accelerate generative and agentic artificial intelligence in the biopharma and medtech sectors. The company, which developed ...

Life sciences dealmaking came back in 2025, and artificial intelligence is poised to drive even more M&A activity in 2026 as companies move from hyping the technology to proving its value in drug ...

As artificial intelligence becomes more integrated into society, this chapter covers how Americans evaluate its potential impact. How do Americans feel about the use of AI in daily life? What ...